These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17983389)
1. Enhancing transplant safety: a new era in the microbiologic evaluation of organ donors? Fishman JA; Greenwald MA; Kuehnert MJ Am J Transplant; 2007 Dec; 7(12):2652-4. PubMed ID: 17983389 [No Abstract] [Full Text] [Related]
2. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety. Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164 [TBL] [Abstract][Full Text] [Related]
3. Organ utilization from increased infectious risk donors: An observational study. L'Huillier AG; Humar A; Payne C; Kumar D Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28981193 [TBL] [Abstract][Full Text] [Related]
4. Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. Grossi PA; Costa AN; Fehily D; Blumberg EA; Kuehnert MJ; Fishman JA; Ison MG; Lattes R; Kotton CN; Lilleri D; Kabanova A; Lanzavecchia A; Gerna G; Razonable RR; Comoli P; Zecca M; Basso S; Ginevri F; Grossi A; Schena FP; Rimola A; Burra P; De Martin E; Rodriguez-Castro KI; Fagiuoli S; Pasulo L; Bruno R; Andreone P; Loggi E; Arena F; Rossolini GM; Sganga G; Cozza V Transplantation; 2012 Mar; 93(5 Suppl):S4-S39. PubMed ID: 22374265 [No Abstract] [Full Text] [Related]
5. Emerging evidence to support not always "just saying no" to SARS-CoV-2 positive donors. Kates OS; Fisher CE; Rakita RM; Reyes JD; Limaye AP Am J Transplant; 2020 Nov; 20(11):3261-3262. PubMed ID: 32502313 [No Abstract] [Full Text] [Related]
6. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Martín-Dávila P; Fortún J; López-Vélez R; Norman F; Montes de Oca M; Zamarrón P; González MI; Moreno A; Pumarola T; Garrido G; Candela A; Moreno S Clin Microbiol Rev; 2008 Jan; 21(1):60-96. PubMed ID: 18202437 [TBL] [Abstract][Full Text] [Related]
7. Novel Donor Transfer Algorithm for Multiorgan and Facial Allograft Procurement. Diaz-Siso JR; Plana NM; Schleich B; Irving H; Gelb BE; Rodriguez ED Am J Transplant; 2017 Sep; 17(9):2496-2497. PubMed ID: 28556472 [No Abstract] [Full Text] [Related]
8. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Len O; Garzoni C; Lumbreras C; Molina I; Meije Y; Pahissa A; Grossi P; Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():10-8. PubMed ID: 24476053 [TBL] [Abstract][Full Text] [Related]
9. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study. Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524 [TBL] [Abstract][Full Text] [Related]
10. Screening of deceased organ donors: no easy answers. Huang RC; Fishman JA Transplantation; 2011 Jan; 91(2):146-9. PubMed ID: 21063244 [TBL] [Abstract][Full Text] [Related]
11. Occult disease in tissue and organ donors--a case for routine autopsy. Burgess BL; Roberts P; Boguski J; Lovell D; Chase DC; Goldman MH Transplantation; 1994 Sep; 58(6):734-5. PubMed ID: 7940699 [No Abstract] [Full Text] [Related]
12. Is it time to reconsider universal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction screening for asymptomatic potential nonlung solid organ transplant donors? Natori Y; Anjan S; Hand J Am J Transplant; 2024 May; 24(5):879-880. PubMed ID: 38266710 [No Abstract] [Full Text] [Related]
13. Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time. Baleriola C; Tu E; Johal H; Gillis J; Ison MG; Law M; Coghlan P; Rawlinson WD Transpl Infect Dis; 2012 Jun; 14(3):278-87. PubMed ID: 22519518 [TBL] [Abstract][Full Text] [Related]
14. Donor disease transmission: minimizing the risks and maximizing the benefits. Monaco AP; Morris PJ Transplantation; 2012 Mar; 93(5 Suppl):S1-3. PubMed ID: 22374264 [No Abstract] [Full Text] [Related]
15. Donation after cardiac death: evaluation of revisiting an important donor source. Moers C; Leuvenink HG; Ploeg RJ Nephrol Dial Transplant; 2010 Mar; 25(3):666-73. PubMed ID: 20061321 [No Abstract] [Full Text] [Related]
16. Screening for West Nile virus in organ transplantation: a medical decision analysis. Kiberd BA; Forward K Am J Transplant; 2004 Aug; 4(8):1296-301. PubMed ID: 15268731 [TBL] [Abstract][Full Text] [Related]
17. The Swiss approach to the COVID-19 outbreak. Moeckli B; Peloso A; Oldani G; Orci LA; Banz V; Dutkowski P; Toso C; Berney T Am J Transplant; 2020 Jul; 20(7):1935-1936. PubMed ID: 32330352 [No Abstract] [Full Text] [Related]
18. Current practices of organ donation and transplantation among different French-speaking countries and regions. Squifflet JP; Barrou B; Rifle G Transplant Proc; 2011 Nov; 43(9):3389-91. PubMed ID: 22099803 [TBL] [Abstract][Full Text] [Related]
19. Organ Donation and Transplantation in Latvia. Ziedina I; Jushinskis J; Lejniece S; Strike E Transplantation; 2019 Nov; 103(11):2211-2213. PubMed ID: 31651730 [No Abstract] [Full Text] [Related]
20. The boundaries of organ donation after circulatory death. Bernat JL N Engl J Med; 2008 Aug; 359(7):669-71. PubMed ID: 18703467 [No Abstract] [Full Text] [Related] [Next] [New Search]